Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Locoregional Recurrence × Fulvestrant × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 120 Neoplasm Metastasis 15 Advanced Breast Cancer 7 Ovarian Neoplasms 6 Neoplasms 5 Breast Cancer Metastatic 5 Prostatic Neoplasms 4 Endometrial Neoplasms 4 Hereditary Sensory and Autonomic Neuropathies 3 Recurrence 2 Lung Neoplasms 2 Hyperglycemia 2 Estrogen Receptor-positive Breast Cancer 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms, Male 2 Squamous Cell Carcinoma of Head and Neck 1 Sex Cord-Gonadal Stromal Tumors 1 Sarcoma, Endometrial Stromal 1 Salivary Gland Neoplasms 1 Recurrent Uterine Corpus Carcinoma 1 Pancreatic Neoplasms 1 Neoplastic Cells, Circulating 1 Multiple Endocrine Neoplasia Type 1 1 Melanoma 1 Malignant Neoplasms of Female Genital Organs 1 Locoregional Recurrence 1 Liposarcoma 1 Lethal Congenital Contracture Syndrome 2 1 Hormone Receptor Positive Breast Carcinoma 1 Hormone Receptor Positive Breast Cancer 1

Interventions

ribociclib 1 exemestane 1 Letrozole 1 Fulvestrant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05467891 2026-02-27

RaPhLRR

Hoosier Cancer Research Network

Phase 2 Recruiting

Locoregional Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡